Tolerability of BTKi in R/R MCL

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

City of Hope

www.cityofhope.org

Breast
Lung
Gastrointestinal
Genitourinary
Leukemia
Lymphoma
Myeloma
Hematologic Malignancies
Head and Neck
General Oncology
Palliative Care
Events

Playback speed

10 seconds

Tolerability of BTKi in R/R MCL

By City of Hope FEATURING Tycel Phillips

200 views

October 12, 2022

This video was recorded prior to FDA approval of Pirtobrutinib on January 26, 2023 in ...
read more ↘ Mantle Cell Lymphoma
↖ read less

Comments 0

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Lymphoma

ASCO® 2024 Insights: "Glofitamab Monotherapy in Patients With Heavil…

2024 ASCO® Annual Meeting Insights Hub

T. Phillips

61 views

ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts With …

Insights from 2023 ASH Annual Meeting

E. Budde

132 views

SOHO 2023 Next Questions: HL

SOHO 2023 Eleventh Annual Meeting

A. Herrera

126 views

SOHO 2023: Tailoring Therapy for PTCL

SOHO 2023 Eleventh Annual Meeting

J. Zain

79 views

SOHO 2023: A Multidisciplinary Approach to the Management of Mycosis…

SOHO 2023 Eleventh Annual Meeting

C. Querfeld

71 views

Cardiac Safety of Zanubrutinib vs. Other BTKis in CLL

City of Hope

A. Danilov

678 views

ASCO® 2023 Insights: "Real-World Outcomes of Brexu-Cel for R/R MCL -…

Insights from 2023 ASCO® Annual Meeting

S. Kambhampati

63 views

ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. Brentu…

ecancer

A. Herrera

73 views

Current Perspective on CAR-T Therapy in Mantle Cell Lymphoma

City of Hope

A. Danilov

158 views